Ionpath + press releases
Web24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million … Web11 mei 2024 · MENLO PARK, Calif., May 11, 2024 -- ( BUSINESS WIRE )--Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving...
Ionpath + press releases
Did you know?
WebIONpath is a California-based biotechnology company that manufactures and supplies spatial proteomics and tissue imaging systems for the healthcare industry. IONpath was … WebIONpath™ is a venture-backed, commercial-stage company, founded by Stanford researchers out of the lab of Dr. Garry Nolan, focused on revolutionizing pathology with Multiplexed Ion Beam Imaging (MIBI) technology. MIBI is a multiplexed imaging platform with unmatched resolution, sensitivity, and throughput.
Web8 nov. 2024 · MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled … WebIonpath’s MIBI™ (multiplexed ion beam imaging) platform breaks through the limitations of traditional immunohistochemistry (IHC), enabling a deeper understanding of the tissue …
Web20 jan. 2024 · MENLO PARK, Calif.-- ( BUSINESS WIRE )-- Ionpath Inc , the leader in high-definition spatial proteomics, today announced that a peer-reviewed research study led by scientists at Stanford University, Washington University, Duke University, and Arizona State University has been published in the journal Cell. Web11 mei 2024 · MENLO PARK, Calif., May 11, 2024--Ionpath, a leader in high-definition spatial proteomics, announced that Thermo Fisher Scientific has made a strategic …
WebIn the complaint, Fluidigm alleges that IONpath’s MIBI Technology infringes Fluidigm’s U.S. Patent Nos. 10,180,386 and 10,072,104. ... This press release contains forward-looking …
WebIn the complaint, Fluidigm alleges that IONpath’s MIBI Technology infringes Fluidigm’s U.S. Patent Nos. 10,180,386 and 10,072,104. ... This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, ... ipchfw1230s1s5Web11 mei 2024 · IonPath, Inc. announced that it has received $123.740413 million in funding from Thermo Fisher Scientific Inc. 05/11/2024 EDT On May 11, 2024, IonPath, Inc. … open theatres near meWeb20 jan. 2024 · Ionpath, Inc., the leader in high-definition spatial proteomics, today announced that a peer-reviewed research study led by scientists at Stanford University, … open theatre cornwallWeb26 aug. 2024 · MENLO PARK, Calif., Aug. 26, 2024 /PRNewswire/ -- Ionpath, Inc., the leader in high-definition spatial proteomics, today announced a new program for … open theatre scarboroughWeb1 nov. 2024 · Accomplished scientist and business executive brings nearly two decades of experience working on commercial strategies and operations in life sciences MENLO … ipch filesWeb5 nov. 2024 · IONpath, Inc., a company revolutionizing multiplexed tissue imaging, launched the MIBIscope™ System, the first commercially available Multiplexed Ion Beam Imaging (MIBI™) system. The MIBIscope enables researchers to image over 40 biomarkers simultaneously at higher sensitivity, resolution, and throughput than existing methods. open the barn door board bookWebMENLO PARK, Calif. — IONpath, Inc., the leader in multiplexed spatial tissue imaging and analysis, today announced the appointment of Brad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product management and application functions to meet the increasing demand for translational … ipc -hfw 2239sp -sa- led-s2 -0360 2mp